Aptabio Therapeutics Inc Ordinary Shares 293780
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- KRW 5,790.00–5,980.00
- 52-Week Range
- —–—
- Bid/Ask
- KRW 5,880.00 / KRW 5,890.00
- Market Cap
- KRW 131.12 Bil
- Volume/Avg
- 24,743 / 145,449
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 402.78
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Aptabio Therapeutics Inc is a South Korean pharmaceutical company involved in discovery and development of selective inhibitors of the NOX family of enzymes and aptamer-based anti-cancer drugs. The product portfolio of the company include Lipofector-Q, Plusfector, Lipofector-EXT, Lipofector-2000, Lipofector-EZ and Lipofector-pMAX.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 26
- Website
- http://www.aptabio.com
Comparables
Valuation
|
Metric
|
293780
|
039200
|
016580
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 7.08 |
Price/Book Value | 2.46 | 10.83 | 0.59 |
Price/Sales | 402.78 | 216.68 | 0.92 |
Price/Cash Flow | — | — | 5.40 |
Price/Earnings
293780
039200
016580
Financial Strength
|
Metric
|
293780
|
039200
|
016580
|
|---|---|---|---|
Quick Ratio | 67.91 | 2.86 | 3.93 |
Current Ratio | 70.27 | 2.94 | 5.30 |
Interest Coverage | −13.10 | −90.11 | 1,345.19 |
Quick Ratio
293780
039200
016580
Profitability
|
Metric
|
293780
|
039200
|
016580
|
|---|---|---|---|
Return on Assets (Normalized) | −27.88% | −20.27% | 7.92% |
Return on Equity (Normalized) | −37.69% | −25.17% | 8.87% |
Return on Invested Capital (Normalized) | −34.07% | −26.91% | 7.89% |
Return on Assets
293780
039200
016580
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Vqxbgpqx | Hjmzyy | $71.2 Bil | |
ZTS
| Zoetis Inc Class A | Shwtmlrhd | Lqknx | $68.3 Bil | |
HLN
| Haleon PLC ADR | Rclzsgcg | Jlbh | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Bnmwcqdr | Wpw | $14.5 Bil | |
VTRS
| Viatris Inc | Xzjzfplg | Jbxl | $13.4 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Gxjtxltkg | Vvfm | $11.9 Bil | |
CTLT
| Catalent Inc | Fpddrsbdn | Vgdhwr | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Wdhvcdhm | Hrrh | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Qxccsyzrq | Htc | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Rpgvzypgw | Zpkldg | $3.5 Bil |